Kala制药(KALA)

1.9673 -0.0127 -0.6414%

今开:1.95昨收:1.98
最高:2.05 最低:1.94
涨停价:0.0跌停价:0.0
总市值:1.27817637E8

Kala制药的热门评论

Takeabreak07-26 21:10

$Kala制药(KALA)$ Symphony Health sales and volume estimates are as follows: For the week ending July 16, 2021: INVELTYS: Approximately $828k (MBS Dollars) in sales and 2,985 pack units (both up +20.7% week-over-week) -About 74% were from new prescriptions and 26% from refill...查看全文

Takeabreak07-22 11:50

$Karyopharm(KPTI)$ $G1治疗(GTHX)$ $Kala制药(KALA)$ BTAI. Value destroyers?? Commercialization is more risky. Lesson learned??? Or patience is a virtue ??查看全文

Takeabreak06-18 22:39

$安帝君斯(AGEN)$ $Kala制药(KALA)$ $Affimed(AFMD)$ BCYC, CGEN 这些都很强势!守住不动,同时间 XBI往下0.8%+。AMRS更是往上1%。吹票时间到了!![加油]查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

Takeabreak06-07 22:17

$Kala制药(KALA)$ 出坑了!! 1. 天热了, 要开空调了, 干眼症要爆发了! 2. 疫苗都打好了, 该找医生的要去找医生了! 看到有竟然目标价设40刀的!!!查看全文

7X24快讯06-08 00:02

美股纳米生物概念股集体上涨,Arbutus生物制药涨超17%,太平洋生物科技涨超7%,剪头制药、诺瓦瓦克斯医药涨超5%,Selecta生物科学、Kala制药涨超4%。查看全文

Takeabreak05-07 11:19

$Kala制药(KALA)$ 6刀5刀分别加了,浮亏较大。KPTI,BTAI,GTHX 也都不行,好在轻仓,确实只能是value play查看全文

Takeabreak04-23 21:56

$Kala制药(KALA)$ 重新站上8刀。财报有花头。今年目标15刀查看全文

Kala制药(KALA)05-06 04:06

$Kala制药(KALA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-21-005904 Act: 34 Size: 6 MB 网页链接查看全文

美股市场有望回暖,这两只小摩所选股真能直冲云霄?

美股研究社04-15 17:24

本文作者:Marty Shtrubel 根据摩根大通首席执行官杰米•戴蒙(Jamie Dimon)的说法,美国正处于经济繁荣的风口浪尖,这种繁荣至少可以推动到2023年。戴蒙将强劲增长的前景归因于几个原因。 戴蒙表示:“我毫不怀疑,随着过度储蓄、新的刺激性储蓄、巨额赤字支出、更多的量化宽松政策、新的潜在基础...查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的最新评论

首次持股声明

Kala制药(KALA)10-20 04:12

$Kala制药(KALA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-21-004906 Size: 10 KB 网页链接查看全文

持股变动声明

Kala制药(KALA)10-20 04:12

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-004907 Size: 5 KB 网页链接查看全文

美股滚雪球10-19 15:48

$Esperion(ESPR)$ 裁员40%,$Kala制药(KALA)$ 药物获批后,快跌成毛票,biotech的商业化比研发还难。$百济神州(BGNE)$的商业化不一定会比其他biotech差,但一定不会比大药企好。查看全文

当期报告

Kala制药(KALA)10-18 20:12

$Kala制药(KALA)$ 8-K Current report, item 5.02 Accession Number: 0001558370-21-013248 Act: 34 Size: 159 KB 网页链接查看全文

超过5%股东持股披露「修订」

Kala制药(KALA)10-15 05:06

$Kala制药(KALA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000947871-21-001065 Act: 34 Size: 76 KB 网页链接查看全文

季度财报

Kala制药(KALA)08-06 04:06

$Kala制药(KALA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-21-010528 Act: 34 Size: 7 MB 网页链接查看全文

当期报告

Kala制药(KALA)08-05 19:06

$Kala制药(KALA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-010375 Act: 34 Size: 385 KB 网页链接查看全文

Takeabreak07-26 21:10

$Kala制药(KALA)$ Symphony Health sales and volume estimates are as follows: For the week ending July 16, 2021: INVELTYS: Approximately $828k (MBS Dollars) in sales and 2,985 pack units (both up +20.7% week-over-week) -About 74% were from new prescriptions and 26% from refill...查看全文

Takeabreak07-22 11:50

$Karyopharm(KPTI)$ $G1治疗(GTHX)$ $Kala制药(KALA)$ BTAI. Value destroyers?? Commercialization is more risky. Lesson learned??? Or patience is a virtue ??查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的公告

$Kala Pharmaceuticals, Inc.(KALA)$ CT ORDER - Confidential treatment order: n Filed: 2017-07-20 AccNo: 9999999997-17-007610 Size: 10 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ EFFECT - Notice of Effectiveness: n Filed: 2017-07-19 AccNo: 9999999995-17-001860 Size: 1 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ CT ORDER - Confidential treatment order: n Filed: 2017-07-20 AccNo: 9999999997-17-007610 Size: 10 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ SC 13G - Statement of acquisition of beneficial ownership by individuals: n Filed: 2017-07-31 AccNo: 0001641080-17-000005 Size: 18 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ EFFECT - Notice of Effectiveness: n Filed: 2017-07-19 AccNo: 9999999995-17-001860 Size: 1 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report: n Filed: 2017-07-25 AccNo: 0001104659-17-046802 Size: 292 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ SC 13G - Statement of acquisition of beneficial ownership by individuals: n Filed: 2017-07-31 AccNo: 0001641080-17-000005 Size: 18 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ S-8 - Securities to be offered to employees in employee benefit plans: n Filed: 2017-07-21 AccNo: 0001104659-17-046276 Size: 132 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report: n Filed: 2017-07-25 AccNo: 0001104659-17-046802 Size: 292 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 8-A12B - Registration of securities [Section 12(b)]: n Filed: 2017-07-14 AccNo: 0001104659-17-045043 Size: 20 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24